Get the Stockscreener App
1.845
7.75%
-0.155
After Hours:
1.845
ProMIS Neurosciences Inc. stock is currently priced at $1.845, with a 24-hour trading volume of 7,783.
It has seen a -7.75% decreased in the last 24 hours and a -0.81% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $1.91 pivot point. If it approaches the $1.81 support level, significant changes may occur.
Previous Close:
$2.00
Open:
$1.87
24h Volume:
7,783
Market Cap:
$34.98M
Revenue:
-
Net Income/Loss:
$-16.90M
P/E Ratio:
-0.7096
EPS:
-2.6
Net Cash Flow:
$-11.64M
1W Performance:
-2.38%
1M Performance:
-0.81%
6M Performance:
+36.67%
1Y Performance:
+0.00%
1D Range:
$1.79
$1.9602
52W Range:
$0.95
$3.10
ProMIS Neurosciences Inc. Stock (PMN) Company Profile
Name
ProMIS Neurosciences Inc.
Sector
Industry
Phone
416 847 6898
Address
1920 Yonge Street, Suite 200, Toronto
ProMIS Neurosciences Inc. Stock (PMN) Latest News
ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent Highlights - GlobeNewswire
GlobeNewswire
ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent Highlights
GlobeNewswire Inc.
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.22% - MSN
MSN
Is ProMIS Neurosciences Inc's (TSE:PMN) CEO Paid At A Competitive Rate? - Yahoo Movies Canada
Yahoo Movies Canada
Critical Contrast: ProMIS Neurosciences (NASDAQ:PMN) vs. Bullfrog AI (NASDAQ:BFRG) - Defense World
Defense World
Global Multiple System Atrophy (MSA) Therapeutics Market Set to Soar, Predicted to Reach US$ 211.1 Million by 2033 ... - Market Research Blog
Market Research Blog
ProMIS Neurosciences Inc. Stock (PMN) Financials Data
ProMIS Neurosciences Inc. (PMN) Net Income 2024
PMN net income (TTM) was -$16.90 million for the quarter ending September 30, 2023, a -29.57% decrease year-over-year.
ProMIS Neurosciences Inc. (PMN) Cash Flow 2024
PMN recorded a free cash flow (TTM) of -$11.64 million for the quarter ending September 30, 2023, a +29.60% increase year-over-year.
ProMIS Neurosciences Inc. (PMN) Earnings per Share 2024
PMN earnings per share (TTM) was -$1.95 for the quarter ending September 30, 2023, a -11.43% decline year-over-year.
About ProMIS Neurosciences Inc.
ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a TDP-43; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
0.77%
1.20%
Cap:
|
Volume (24h):